phospho-p4442MAPK相关论文
The inhibition of the pemetrexed-activated, MAPK pathway via sorafenib is involved in the synergisti
Background The effect of combined administration of multi-targeted receptor tyrosine kinase (RTK) inhibitor (sorafen......
